Download the full pdf of Issue 2
In a high-tech suite at Barnes-Jewish Hospital, an epilepsy patient is wired to monitoring equipment, waiting for a seizure to begin. Doctors have weaned him off his medication so they can find the focal point of his severe seizure problem, somewhere within his brain. By the end of this assessment, they will likely know whether surgery – performed by experienced Washington University neurosurgeons at Barnes-Jewish Hospital – can bring him life-changing relief.
Barnes-Jewish Hospital and Washington University School of Medicine are now among 15 sites in the United States participating in a clinical trial that could revolutionize how some heart patients are treated. “Depending on the outcome of the trial, this might reshape the whole approach surgeons and cardiologists take toward treating aortic valves,” says John Lasala, MD, PhD, Washington University cardiologist and director of the cardiac catheterization lab at Barnes-Jewish. “This could be gigantic.”
According to the American Cancer Society, the five-year survival rate for all stages of pancreatic cancer is a grim 5 percent. But thanks to pioneering techniques and treatments developed at the Siteman Cancer Center, the likelihood of defeating the disease is growing.
Also In this Issue
- Breakthroughs: The Gamma Knife radiosurgery system uses targeted beams of radiation, 3-D biopsy system for prostate cancer, and the O-Arm scanner for spine patients.
- Side by Side: Two Faces to Clinical Trials: Rhonda Levan, breast cancer clinical trial participant, has been given a new lease on life, thanks to Matthew Ellis, MB, BChir, PhD, a Washington University medical oncologist at the Siteman Cancer Center.
Innovate Magazine is published 4 times a year. To request a complimentary subscription Innovate, please subscribe here.
To receive a monthly e-mail newsletter with highlights from Innovate and Barnes-Jewish news, please subscribe here.